All India Drug Action Network

The Delhi High Court today quashed the government notification on March 10 that banned 344 fixed-dose combination drugs.

Supreme Court says NGO can petition govt on essential drugs

The Supreme Court has said a group seeking to lower drug prices should be allowed to petition the country's government to review its pricing policy for medicines deemed essential, according to a court order published this week.

Pharma body challenges government‘s method of pricing

The government wants more time to table its new drug pricing norms. The Supreme Court has deferred hearing the matter till the 12th of December. Meanwhile, the pharma pricing policy has been challenged by the All India Drug Action Network (AIDAN).

Pharma body challenges drug pricing policy in SC

Drug price controls based on market based rate, which was cleared by the cabinet is challenged in the Supreme Court through a public interest litigation filed by All India Drug Action Network (AIDAN), reports CNBC-TV18‘s Rituparna Bhuyan.

Drug cos want market based pricing but may hurt consumers

With GoM set to take a call on framing the drug pricing policy, India's largest association of pharma companies has submitted a study to show the pricing formula should be market based. But critics say this could end up in increasing drug prices reports CNBC-TV18's Archana Shukla.